SITO Partners with Ribbow Media for Theatrical Film Release

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
22
SITO Partners with Ribbow Media for Theatrical Film Release Promotion Program

JERSEY CITY, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- SITO Mobile, Ltd.  (NASDAQ: SITO ) (“SITO” or the “Company”), an insights-driven consumer behavior and location sciences company, announced today a partnership with Ribbow Media Group to deliver media to promote movies beginning in Q3 and Q4 of 2018.

The co-promotion agreement incorporates Ribbow’s proprietary digital media process and SITO’s location data and attribution capabilities to develop integrated media solutions to drive verified traffic into theaters for the movies. Ribbow specializes in movie promotions and has worked on blockbusters such as I Can Only Imagine and War Room . SITO has worked on films such as Case for Christ and Your Name the 9th-highest-grossing non-English film worldwide. 

“I couldn’t be more excited to add SITO’s world-leading location data and attribution technology and services to the reputation and results we’ve built after working on over 100 films in the last 6 years,” said Ribbow Media Group’s founder and CEO Ash Greyson. SITO CEO Tom Pallack added, “We’re pleased to be working with Ribbow and their well-established capabilities and deep knowledge of the theatrical film business.”

About SITO Mobile, Ltd.

SITO is a leading mobile data technology company that provides brands customized, data-driven solutions spanning strategic insights and media campaign delivery services. Through Consumer Behavior and Location Sciences™, SITO explores the consumer journey and presents powerful strategic knowledge assets and actionable insights for executives and strategic decision makers looking to understand and influence consumer behaviors.

Brands and agencies rely on SITO as a strategic partner for real-time understandings of customer movements, interests, actions, associations, and experiences, ultimately providing increased clarity for better business decisions. The Company is headquartered in Jersey City, New Jersey and its common stock is publicly traded on the NASDAQ Stock Market under the ticker symbol “SITO.” For more information regarding SITO’s science, technology and solutions spanning media and research, please visit  www.sitomobile.com .

About Ribbow Media Group

Ribbow Media Group is a digital media and data services firm that combines science, art and empathy to deliver results for the entertainment industry. Known as Hollywood’s secret weapon, Ribbow has redefined digital success for many premier studios. With dozens of films managed over the last 6 years, Ribbow has helped deliver more than $750 million in box office revenue. Understanding how algorithms interact with real human behavior gives Ribbow a true edge that redefines success at the box office.  For more information on a better approach to media to make your big idea a box office hit, contact Ash Greyson, hello@ribbowmediagroup.com .

Cautionary Statement Regarding Certain Forward-Looking Information  

This press release contains forward-looking statements. These statements are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include statements concerning the following: SITO’s plans and initiatives; our possible or assumed future results of operations; our ability to attract and retail customers; our ability to sell additional products and services to customers; our competitive position; our industry environment; and our potential growth opportunities. You should not place undue reliance on forward-looking statements, because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under “Risk Factors” in our Annual Report on Form 10-K, for the year ended December 31, 2017, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, and the reports we file with the Securities and Exchange Commission, or the SEC. Actual events or results may vary significantly from those implied or projected by the forward-looking statements due to these risk factors. No forward-looking statement is a guarantee of future performance. You should read our Annual Report on Form 10-K, our Quarterly Report on Form 10-Q and the documents that we reference in our Annual Report on Form 10-K, our Quarterly Report on Form 10-Q and have filed as exhibits thereto with the SEC, with the understanding that our actual future results and circumstances may be materially different from what we expect. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and we undertake no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as may be required by applicable law. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

Contact: Investor Relations Rob Fink Hayden IR Phone: 646.415.8972 Email: SITO@haydenir.com

SITO Communications Bruce H. Rogers Head of Marketing and Communications Phone: 917-783-8159 Email: bruce.rogers@sitomobile.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 6

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 1

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 1

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 3

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 2

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 1

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 3

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Investor Conferences to Watch This Quarter for Growth

Updated Category News Views 256

Introduction to Q1 Investor Conferences This year has begun with a dynamic mix of geopolitical events that have positively impacted domestic energy-sector stocks. As we venture into 2026, the buzz around technological advancements, especially in artificial intelligence, is palpable. Investors are keenly awaiting insights and trends that will be presented at various...

Continue Reading
Triton Digital Unveils U.S. Podcast Rankings for November 2024

Updated Category News Views 191

Overview of the November 2024 Podcast Metrics Triton Digital, a leading provider of technology and services in the digital audio and podcasting sector, has unveiled its reporting period for November 2024, covering from November 4 to December 1. This release comes from Triton’s Podcast Metrics measurement service, which offers critical insights into podcast performances...

Continue Reading
Treasury Bonds Auction Insights: RIKB 26 1015 & RIKB 38 0215

Updated Category News Views 150

Overview of Treasury Bonds Auction Results In a recent auction, two significant treasury bonds were featured: RIKB 26 1015 and RIKB 38 0215. The auction process is a crucial activity in the finance world, presenting opportunities for investors to acquire bonds issued by the government. Each bond serves different funding needs, making it essential to assess their...

Continue Reading
DeepQure's New Clinical Leadership: A Vision for Hypertension Care

Updated Category News Views 162

DeepQure Welcomes New Global Vice President DeepQure, a trailblazer in innovative treatments for hypertension, has made a significant step forward with the recent appointment of Jason G. Jones as the Global Vice President of Clinical & Regulatory Affairs. This strategic move is expected to amplify DeepQure's ambitions as it seeks to redefine hypertension management with...

Continue Reading
Wave Life Sciences Unveils Promising Data for WVE-007 Obesity Therapy

Updated Category News Views 236

Wave Life Sciences Presents Preclinical Findings at ObesityWeek 2025 Wave Life Sciences Ltd. (NASDAQ: WVE), a pioneering biotechnology firm, is excited to share breakthrough preclinical data on WVE-007, an innovative siRNA therapeutic targeting obesity. This research will be spotlighted in a poster presentation at ObesityWeek 2025, which features insights into how WVE-007...

Continue Reading